all report title image

NERVE MONITORING SYSTEM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Nerve Monitoring System Market, By Product (Nerve Monitor, Electrodes, Probes, Accessories), By Technology (Electroencephalogram (EEG), Electromyography (EMG), Electrocorticography (ECOG), Evoked Potential (EP)), By Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : May 2024
  • Code : CMI6951
  • Pages :167
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Key Developments

  • In April 2023, Neuspera Medical, a medical device company, announced that it had received U.S. Food and Drug Administration (FDA) approval for the next-generation Neuspera ultra-miniaturized system. The system comprises a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.
  • In December 2022, WISE S.r.l., a medical device company, announced that it had received an approval from U.S. Food and drug Administration for its WISE Cortical Strip, a single-use device for neuromonitoring. The new device has been designed for Intra Operative Neurophysiological Monitoring (IONM) from the surface of the brain.
  • In April 2022, Assure Holdings Corp., an intraoperative neuromonitoring company, signed a group purchasing agreement ('GPO') for intraoperative neuromonitoring services with Conductiv, the only end-to-end third-party lifecycle improvement company. The agreement allows Conductiv members, which includes 500 hospitals and surgery centers and more than 50 health systems, to take advantage of special pricing and pre-negotiated terms for Assure's Joint Commission accredited intraoperative neuromonitoring services.
  • In February 2022, Medtronic, a global medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for InterStim X, the personalized system to deliver sacral neuromodulation (SNM) therapy
  • In October 2020, Medtronic, a global medical technology company, announced that it had received an approval from U.S. Food and Drug Administration (FDA), for the NIM Vital nerve monitoring system that enables physicians to identify, confirm, and monitor nerve function to reduce the risk of nerve damage during head and neck surgery. The NIM Vital system uses proprietary technology to provide detailed intraoperative nerve condition data that informs surgical strategy, increases operative efficiency and precision, and helps protect patients' quality of life.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.